Emerald Health Therapeutics
Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) (Emerald) is a Health Canada Licensed Producer of medical cannabis and is significantly expanding production capacity in anticipation of the legal adult-use cannabis market in Canada, slated for October 17, 2018. Emerald's multi-phase expansion plan includes a joint venture of 1.1 million square feet with an additional 3.7 million square foot option, as well as 575K square feet in wholly owned, established/planned grow facilities. The vertically integrated, seed-to-sale enterprise combines core competencies in pharmaceutical innovation and large-scale agriculture. Our ambition is to be at the forefront of developing knowledge and products that provide wellness and health benefits from cannabis.
Meet the Companies Capitalizing on the Canadian Cannabis Industry
August 23, 2018, 10:20 am - 11:05 am PDT
Emerald Health Therapeutics: An Emerging Leader in the Global Cannabis Industry
August 23, 2018, 11:25 am - 11:45 am PDT
Presented by: Rob Hill, CPA, Chief Financial Officer, Emerald Health Therapeutics Inc.
The Endocannabi-What? The Medical (and Investment) Potential of Cannabis
August 25, 2018, 2:15 pm - 3:00 pm PDT
Presented by: Jim DeMesa, MD, MBA, Chief Executive Officer, Emerald Health Pharmaceuticals Inc.
Focus: CANNABIS INVESTMENTS